Tracking Medicare news, policy, and coverage changes.
(MedPage Today) -- An investigational vaccine targeting the Escherichia coli pathogens that commonly cause infections didn't show a protective effect in older adults, the phase III E.mbrace trial found. Among over 17,000 participants ages 60 and...
Read full article →(MedPage Today) -- Confirmed cases in Congo's Ebola outbreak have surpassed 9,000, with more than 4,300 deaths, as health authorities struggle to contain an outbreak spreading across seven provinces, according to government figures released Tuesday...
Read full article →(MedPage Today) -- CHEYENNE, Wyo. -- A Wyoming microbiology graduate student from China has been arrested on accusations she poisoned the tea of a colleague who had pending patents and with whom she didn't get along, then tried to flee…
Read full article →(MedPage Today) -- Note that some links may require registration or subscription. Nearly 113,000 bottles of generic extra-strength acetaminophen (Tylenol) sold through Amazon were recalled over reports of discolored tablets, according to the FDA...
Read full article →Centene is the latest insurer to adopt a gold card program as states and the Trump administration push for prior authorization reform.
Read full article →The nonprofits will merge on Nov. 1 after securing approval from state regulators, the systems announced this week.
Read full article →Prosecutors say the company filled unnecessary prescriptions that fueled the opioid epidemic. A spokesperson for CVS said the company admitted to no wrongdoing and “strongly disagreed” with the case’s claims.
Read full article →The resulting nonprofit system would be Illinois' largest by hospital count and comprise nearly $11 billion in annual operating revenue.
Read full article →People with serious mental illness often face significant barriers to getting the care they need. In this week's episode of "Podnosis," we explore how Amae Health is working to address gaps in the system by bringing psychiatric care, physical healthcare…
Read full article →The company’s core product is a physician-ordered genetic test for undiagnosed rare disease patients, who typically face a seven-year diagnostic odyssey before getting answers.
Read full article →Since its expansion nationwide last year, Allara has added urgent care visits, brought on more internal medicine providers and launched more supplements and medication delivery services.
Read full article →The company secured a $12.5 million series A extension following its $10 million series A round announced in September to continue scaling an AI platform for end-to-end healthcare operations.
Read full article →